News

City of Hope's New Discovery Offers Hope Against Blood Cancers

City of Hope's New Discovery Offers Hope Against Blood Cancers

City of Hope's Groundbreaking Research on Cancer Therapy

Scientists at City of Hope, one of the leading cancer research and treatment institutions in the U.S., have made a significant breakthrough in understanding how certain cancer cells evade CAR T cell therapy. This innovative therapy works by leveraging the immune system to identify and attack malignant cells, particularly in blood cancers such as leukemia and lymphoma.

The Role of YTHDF2 in Cancer

Through their research, the team identified a protein known as YTHDF2, which plays a vital role in the growth and spread of blood cancers. By targeting this protein, the researchers aim to create more effective, personalized treatments that can enhance patient survival rates.

Introducing CCI-38

To combat the effects of YTHDF2, the City of Hope team developed a new compound called CCI-38. This compound specifically targets and suppresses YTHDF2's activity, which potentially diminishes the growth of aggressive blood cancers. This promising approach could lead to improved efficacy in existing CAR T cell therapies.

Challenges in Treating Blood Cancers

One of the major hurdles in blood cancer treatment is a phenomenon known as “antigen escape.” The primary target of CAR T therapies is the CD19 protein found on cancer cells. Unfortunately, in many cases, these cancer cells reduce or completely lose the expression of CD19, which diminishes the effectiveness of the treatment.

Understanding Antigen Escape

The ability of cancer cells to evade detection significantly complicates treatment strategies, affecting nearly half of all patients. Ongoing research is underway to find ways to target multiple cancer markers to combat this issue more effectively.

The Mechanism of YTHDF2

YTHDF2 aids cancer cells in generating steady energy supplies that empower their growth and malignancy. Furthermore, it plays a crucial role in shielding these cells by reducing antigen biomarkers' visibility, which would typically alert the immune system to their presence. Remarkably, excessive levels of YTHDF2 can even transform healthy blood cells into malignant ones, as evidenced in mouse study trials.

The Impact on Patient Care

Reducing the need for extensive follow-up treatments may lead to improved long-term survival for patients, lowering the likelihood of recurrence while minimizing side effects and healthcare costs. This holistic approach is vital for advancing cancer care.

Future Directions and Studies

City of Hope is committed to unraveling YTHDF2's biological significance further to develop innovative strategies that prevent tumor cells from escaping immune detection. This research heralds a new era of personalized treatment methods designed specifically for patients whose cancers either do not respond to therapies or relapse after initially being treated successfully.

Implications for Broader Cancer Treatment

The advancements made through the study of YTHDF2 extend beyond blood cancers to potentially enhance treatment protocols for various cancers and serious autoimmune disorders. The next phase of research will delve deeper into improving CCI-38's safety and effectiveness and creating clinical trials to evaluate these new therapies.

About City of Hope

City of Hope's mission is to provide hope and healing to all impacted by cancer and diabetes. Since its inception in 1913, City of Hope has evolved into one of the largest cancer research and treatment organizations in the U.S. and a leading center for diabetes research. Notably, City of Hope has paved the way for numerous breakthrough cancer therapies and lifesaving treatments.

Frequently Asked Questions

What is CAR T cell therapy?

CAR T cell therapy is an innovative treatment that harnesses the body's immune system to fight cancer, particularly effective against blood cancers.

What role does YTHDF2 play in cancer?

YTHDF2 promotes the survival and proliferation of cancer cells while helping them evade the immune system.

How could CCI-38 improve cancer treatment?

CCI-38 aims to inhibit YTHDF2, leading to a decrease in the growth of aggressive blood cancers and enhancing the effectiveness of CAR T cell therapy.

What is antigen escape?

Antigen escape is a process by which cancer cells reduce or lose specific proteins, like CD19, that CAR T therapies target, thus compromising treatment efficacy.

How can these discoveries affect future cancer therapies?

The research on YTHDF2 may contribute to more personalized and effective treatment strategies for patients battling various forms of cancer.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Insight Into Midland TX Real Estate Sales Timing

Updated Category News Views 92

How Fast Do Homes Move in Midland? This ain't my first rodeo predicting the real estate rollercoaster in Texas. Midland's housing market is one nifty beast—homes can either sell like hotcakes or just sit gathering dust. You got HelloNation pulling in DeLaura Gammage, a pro who knows the terrain like the back of her hand, to spell out the why and how long it'll take to...

Continue Reading
Rakuten Medical Fires Up Phase 1 Trial for RM-0256 Therapy

Updated Category News Views 272

Taking Aim at Refractory Tumors in Japan Get this—Rakuten Medical is stepping into the ring with their new cancer-busting tactic, RM-0256 photoimmunotherapy, right in Japan. We're talking about a Phase 1 trial that'll throw a new kind of punch at solid tumors, specifically targeting troublesome skin cancers that don’t seem to play nice with current treatments. Now,...

Continue Reading
Grupo Supervielle's Q3 2026: Back to Growth Path

Updated Category News Views 49

Mounting Momentum in Loans and Asset Quality Grupo Supervielle, the Argentine financial player, has been tinkering with its gears to navigate the bumpy roads of 2026. In the third quarter, the company reports a gentle uptick in net loans—up 1.3% sequentially. This was particularly felt in September, with loans increasing 3.7%. Holding Their Own Against the Industry...

Continue Reading
AvidXchange Acquisition Faces Fairness Investigation

Updated Category News Views 233

Unpacking the AvidXchange Turmoil Staring at the ticker tape feels like watching a drama unfold, and today it's all about AvidXchange Holdings, Inc. (NASDAQ: AVDX). Levi & Korsinsky, LLP has launched an investigation into the fairness of its acquisition, and let me tell you, when the suits start poking around, it means someone smells a rat. The deal in question? A buyout...

Continue Reading
Sinch Appoints Jonas Dahlberg as New CEO: A Strategic Move

Updated Category News Views 74

A Change at the Helm: Dahlberg Takes Charge Here we go, folks—Sinch, that global powerhouse in customer communications, just got itself a new captain. Jonas Dahlberg is now officially the CEO, after warming the acting CEO seat since June. This ain't your ordinary office shuffle. It's a calculated chess move in the high-stakes tech world. Dahlberg's Path to the Top This...

Continue Reading
Sharon Stuart's Quest for Her Hidden Origins

Updated Category News Views 123

Delving Into Identity: A Personal Odyssey In a world where everyone seems to be searching for something, Sharon Stuart's quest is etched with the raw need to uncover her real origins. Abandoned as a newborn in the gritty streets of Oakland, she grew up grappling with looming questions about what made her who she is. Her journey is captured in her memoir, "Existing Without...

Continue Reading
Crocs to Present at Key Industry Conferences

Updated Category News Views 148

Crocs Set to Step into the Spotlight Alright, if there's one thing about Crocs, Inc. (NASDAQ: CROX) that never fails to surprise, it's how they constantly keep everyone on their toes. The iconic casual footwear brand with its whimsical, love-it-or-hate-it reputation is strapping in for not one but two hefty conferences. They've circled November 19 and December 1, 2026, on...

Continue Reading
Sabre Unveils AI Travel Tech: A Bold New Frontier

Updated Category News Views 92

Sabre's Game-Changing AI Travel Integration I'm no stranger to bold moves in the travel industry, but what Sabre's rolling out tomorrow might just be the biggest leap we've seen in a while. They're unleashing what's called the first global travel plug-in within Grok Bot, marking a significant shake-up in the travel tech sphere. Too many tech upgrades in this business...

Continue Reading
Chicken Production Rises Amid Meat Market Shifts

Updated Category News Views 187

Protein Markets Scramble: Chicken Production Climbs Here’s a tasty tidbit that might just have investors reeling: the USDA says chicken production will be cruising on the up, whereas beef is taking a bit of a backseat. Yep, the big birds are flying higher, and the cows, well, they're just mooing a little softer. And what's that mean for big players like Tyson...

Continue Reading
PolyBio Convergence Summit Tackles Aging, Chronic Illness

Updated Category News Views 211

Kicking Off The Convergence: Pathogens in Focus Here's a gathering that's set to challenge how we think about lingering illnesses and aging. PolyBio Research Foundation is bringing a powerhouse of brains to the table with their inaugural Convergence Summit. It's more than just science talk; it's a chance to push boundaries in understanding how pathogens stick around and...

Continue Reading

Top 5 Most Recently Viewed Articles

Atlantic International Corp. Achieves Major Contract Success

Updated Category News Views 124

Atlantic International Corp. Secures Major Contract for Growth Atlantic International Corp. (Nasdaq: ATLN), a prominent player in the field of strategic staffing, recently achieved a significant milestone through its subsidiary, Lyneer Staffing Solutions. This achievement comes in the form of a multi-million dollar manufacturing contract with a leading food manufacturer....

Continue Reading
Santa Cruz County's Bold Move Against Cigarette Filters

Updated Category News Views 144

Santa Cruz County's Bold Action Against Cigarette Filters In a landmark decision, Santa Cruz County has become the first jurisdiction globally to implement a ban on the sale of cigarettes with filters. This crucial measure aligns perfectly with the upcoming World No Tobacco Day, highlighting the county's commitment to both public health and environmental sustainability....

Continue Reading
OceanaGold Embraces New Fast-Track Approvals for Growth

Updated Category News Views 154

OceanaGold Welcomes New Fast-track Approvals Act OceanaGold Corporation (TSX: OGC) (OTCQX: OCANF) has embraced the recent passing of the Fast-track Approvals Act by the New Zealand Parliament. This important legislative move is designed to streamline the consenting process for regionally and nationally significant infrastructure and development projects. With this new...

Continue Reading
Why Debt Repayment Spreadsheets Fail and How to Get Out of Debt

Updated Category Personal Finance Views 113

We have all been told the same basic formula for clearing negative balances: list your liabilities from smallest to largest, choose between the avalanche or snowball method, and cut your spending to the bone. On paper, a debt payoff journey looks like a straightforward mathematical equation. But if you have ever spent a weekend building a beautiful, co

Continue Reading
Elis Reports Own Shares Trading Activity and Future Plans

Updated Category News Views 232

Elis Shares Trading Activity Overview Elis has recently engaged in noteworthy trading activities concerning its own shares. As part of this initiative, Elis has executed buybacks of its own shares under a designated program authorized by the company's shareholders. Details of Recent Share Buybacks According to updated regulations on share buybacks, Elis conducted several...

Continue Reading